FORM OF DIGIRAD CORPORATION UNDERWRITING AGREEMENTUnderwriting Agreement • April 9th, 2019 • Digirad Corp • Electromedical & electrotherapeutic apparatus • New York
Digirad Corporation., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom Roth Capital Partners, LLC (“Roth”) and Aegis Capital Corp. (“Aegis”) are acting as representatives (the “Representatives”), an aggregate of [ ] authorized but unissued shares (the “Firm Shares”) of __% Series A Cumulative Term Preferred Stock, par value $0.0001 per share (the “Series A Preferred Stock”), of the Company. The Company also proposes to sell to the Underwriters, upon the terms and conditions set forth in Section 4 hereof, up to an additional [ ] shares of Series A Preferred Stock (the “Option Shares”). The Firm Shares and the Option Shares are hereinafter collectively referred to as the “Shares”.
